1. Home
  2. EPIX vs MCHX Comparison

EPIX vs MCHX Comparison

Compare EPIX & MCHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EPIX
  • MCHX
  • Stock Information
  • Founded
  • EPIX 2009
  • MCHX 2003
  • Country
  • EPIX Canada
  • MCHX United States
  • Employees
  • EPIX N/A
  • MCHX N/A
  • Industry
  • EPIX Biotechnology: Pharmaceutical Preparations
  • MCHX Business Services
  • Sector
  • EPIX Health Care
  • MCHX Consumer Discretionary
  • Exchange
  • EPIX Nasdaq
  • MCHX Nasdaq
  • Market Cap
  • EPIX 65.3M
  • MCHX 84.3M
  • IPO Year
  • EPIX N/A
  • MCHX 2004
  • Fundamental
  • Price
  • EPIX $1.71
  • MCHX $1.39
  • Analyst Decision
  • EPIX Hold
  • MCHX
  • Analyst Count
  • EPIX 3
  • MCHX 0
  • Target Price
  • EPIX $2.00
  • MCHX N/A
  • AVG Volume (30 Days)
  • EPIX 276.9K
  • MCHX 18.2K
  • Earning Date
  • EPIX 05-08-2025
  • MCHX 05-13-2025
  • Dividend Yield
  • EPIX N/A
  • MCHX N/A
  • EPS Growth
  • EPIX N/A
  • MCHX N/A
  • EPS
  • EPIX N/A
  • MCHX N/A
  • Revenue
  • EPIX N/A
  • MCHX $48,122,000.00
  • Revenue This Year
  • EPIX N/A
  • MCHX $6.83
  • Revenue Next Year
  • EPIX N/A
  • MCHX N/A
  • P/E Ratio
  • EPIX N/A
  • MCHX N/A
  • Revenue Growth
  • EPIX N/A
  • MCHX N/A
  • 52 Week Low
  • EPIX $1.40
  • MCHX $1.23
  • 52 Week High
  • EPIX $7.88
  • MCHX $2.40
  • Technical
  • Relative Strength Index (RSI)
  • EPIX 51.16
  • MCHX 42.07
  • Support Level
  • EPIX $1.74
  • MCHX $1.26
  • Resistance Level
  • EPIX $1.85
  • MCHX $1.50
  • Average True Range (ATR)
  • EPIX 0.08
  • MCHX 0.11
  • MACD
  • EPIX -0.01
  • MCHX 0.01
  • Stochastic Oscillator
  • EPIX 13.33
  • MCHX 40.62

About EPIX ESSA Pharma Inc.

ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.

About MCHX Marchex Inc. Class B

Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.

Share on Social Networks: